We are live on
!
Find out more
enGene Therapeutics
ENGN
ENGN
1.82
USD
-0.01
0.55%
At close
Updated
Sep 4, 4:00 PM EDT
Pre-market
After hours
1.82
0.00
0%
1 day
-0.55%
5 days
-0.55%
1 month
1.68%
3 months
5.81%
6 months
-81.31%
Year to date
-79.44%
1 year
-63.6%
5 years
-90.9%
10 years
-90.9%
New
Increased
Maintained
Reduced
Closed
Mega AUM
Over $200B
Large AUM
$10B to $200B
Mid AUM
$2B to $10B
Small AUM
$250M to $2B
Micro AUM
Under $250M
Less than 10%
Less than 20%
Less than 40%
Less than 60%
Less than 80%
| # | Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|---|
| 26 |
26
Geode Capital Management
Boston,
Massachusetts
| $273K | +$197K | +16,126 | New |
|
| 27 |
CSS
27
Cubist Systematic Strategies
Stamford,
Connecticut
| $165K | +$119K | +9,757 | New |
|
| 28 |
28
Royal Bank of Canada
Toronto,
Ontario, Canada
| $134K | -$366K | -29,930 | -79% |
|
| 29 |
29
JP Morgan Chase
New York
| $4.9K | +$3.54K | +289 | New |
|
| 30 |
30
Qube Research & Technologies (QRT)
London,
United Kingdom
| $237 | +$171 | +14 | New |
|
| 31 |
31
Morgan Stanley
New York
| $136 | – | – | – |
|
| 32 |
32
Goldman Sachs
New York
| – | -$346K | -37,447 | Closed |
|
| 33 |
33
UBS Group
Zurich,
Switzerland
| – | -$17.9K | -1,937 | Closed |
|